The director of the Liver Tumor Program at Texas Children’s Hospital discussed a phase 1 study of CAR NK T-cells in neuroblastoma.
Andras Heczey, MD
Advertisement
Articles by Andras Heczey, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Sangamo Starts Putting BLA for Fabry Disease Gene Therapy Isa-Vec in Front of FDA
2
What the Field of Cell and Gene Therapy Needs Most in the Current Moment
3
Around the Helix: Cell and Gene Therapy Company Updates – December 17, 2025
4
CGTLive®’s Weekly Rewind – December 19, 2025
5